ARCHIVES

DCE Advisors Okay Contract Recompetitions For Epidemiology

This article is from The Cancer Letter archive.

Vol. 20 No. 44 | November 18, 1994

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

As For-Profits Provide Phase I Studies, NCI Seeks to Look Deeper and Learn More

April 6, 2012

Committee To Set Research Agenda On Breast Cancer. Justice Department Appeals Injunction On Stem Cell Research

September 3, 2010

NCI Beings Accelerated Review Of R01s That just Miss Payline

March 29, 1996

Study: Gene Assay Can Provide Valid Prognostic Information

January 31, 2014

In Congress: Mack Urges Stevens To Add $2 Billion To NIH Appropriations

June 13, 1997